Company Update

Ganga Pharmaceuticals' Registrar and Share Transfer Agent, KFIN Technologies, has confirmed timely submission of data on dematerialized and rematerialized shares for the quarter ending June 30, 2026. This process is crucial for maintaining accurate shareholder records and ensures the company's compliance with investor-related regulatory requirements.

It indicates smooth operational handling of share transfers and record-keeping, essential for transparency and investor confidence.